Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children
Susceptibility to Artemisinin-based combination therapies (ACTs) currently remains high among the...
ABOUT
ASAAP Project
ASAAP is a clinical trial evaluating the efficacy, safety, tolerability and pharmacokinetics of a new antimalarial combination drug, with particular focus on its successful application in one of the largest and most vulnerable demographics of Africa – i.e. children 0-10 years old.
ABOUT
ASAAP Plus
ASAAP Plus is a 24-month project awarded by the HORIZON-JU-GH-EDCTP3-2023-01-02 program to successfully finalize EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic. This grant supports the remaining activities under ASAAP RIA2017MC-2022-EDCTP2 until December 2025.
Institutions
ASAAP Consortium
Work Plan
ASAAP Work Packages
Current activities
News & Updates
-
11 Mar, 2024Industry Updates -
13 Mar, 2019Industry UpdatesASAAP clinical study of malaria treatment for children has started
A large clinical study evaluating a triple plus combination of antimalarials...
Clinical evaluation of AntimalarialS tri-therapy with AtovAquone Proguanil for malaria treatment in African children.
Funders
Address
KCCR, South-end Asuogya Road,
KNUST, Kumasi, Ghana
Contact
© Copyright 2024 by LugiWeb